Clinical Observation of Gefitinib with Pericardial Perfusion for 
Advanced Non-small Cell Lung Cancer

Background and objective Epidermal growth factor receptor (EGFR) mutation non-small cell lung cancer (NSCLC) is an important subtype of lung cancer. The incidence of malignant pericardial effusion (MPCE) in EGFR-mutant NSCLC patients is high. However, there are few researches on the treatmentof this...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xiaomeng WANG, Jin CHEN, Jiaqi YAO, Renhua GUO
Médium:	Artigo
Jazyk:	Chinês
Vydáno:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-01-01
Edice:	Chinese Journal of Lung Cancer
Témata:	Malignant pericardialeffusion Gefitinib Hydroxycamptothecine Lung neoplasms
On-line přístup:	http://dx.doi.org/10.3779/j.issn.1009-3419.2018.01.10
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!